[8-K] HELIUS MEDICAL TECHNOLOGIES, INC. Reports Material Event
Solana Company, formerly known as Helius Medical Technologies, Inc., reported that it issued a press release announcing its financial results for the quarter ended September 30, 2025. The release also includes a business update and details for a conference call to discuss these results and recent corporate highlights. This information is provided as Exhibit 99.1 and is furnished, not filed, under the securities laws, meaning it is not automatically incorporated into other SEC filings unless specifically referenced.
- None.
- None.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| ||
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading Symbol(s) |
| Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02Results of Operations and Financial Condition.
On November 18, 2025, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025, a business update, and information regarding a conference call to discuss these financial results and recent corporate highlights. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit No. |
| Description |
99.1 | Press Release dated November 18, 2025. | |
104 | Cover Page Interactive Data File (embedded within Inline XBRL document). |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SOLANA COMPANY. | ||
|
|
|
|
Dated: November 18, 2025 |
| By: | /s/ Jeffrey S. Mathiesen |
|
|
| Jeffrey S. Mathiesen |
|
|
| Chief Financial Officer, Treasurer and Secretary |
3
FAQ
What did Solana Company (HSDT) report in its latest 8-K?
Solana Company reported that it issued a press release announcing its financial results for the quarter ended September 30, 2025, along with a business update and conference call details.
Which period do the reported Solana Company (HSDT) results cover?
The reported results cover Solana Company’s financial performance for the quarter ended September 30, 2025.
What is Exhibit 99.1 in Solana Company’s 8-K filing?
Exhibit 99.1 is the press release dated November 18, 2025, which contains Solana Company’s quarterly financial results, business update, and information about the related conference call.
Is the financial information in Solana Company’s 8-K considered filed with the SEC?
No. The information under Item 2.02, including Exhibit 99.1, is furnished and is not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, unless specifically incorporated by reference elsewhere.
Did Solana Company change its name from Helius Medical Technologies?
Yes. The filing notes that Solana Company was formerly known as Helius Medical Technologies, Inc.
On which exchange does Solana Company (HSDT) trade and what class of stock is listed?
Solana Company’s Class A Common Stock, with a par value of $0.001 per share, trades on The Nasdaq Stock Market LLC under the symbol HSDT.
